Substituted pyrrolo[2,3-d]pyrimidines as HER2 inhibitors
AssigneeTaiho Pharmaceutical Co., Ltd.
InventorsMasayuki Nakamura, Takahiro Asai, Satoru Iguchi, Kei Oguchi
Life of this patent
Estimating the term…
Loading patent…
AssigneeTaiho Pharmaceutical Co., Ltd.
InventorsMasayuki Nakamura, Takahiro Asai, Satoru Iguchi, Kei Oguchi
Estimating the term…
Provided are a novel pyrimidine compound that inhibits HER2 activity and exhibits brain penetration properties, or a salt thereof, and a pharmaceutical composition comprising the same. A compound represented by the following formula (I), or a salt thereof: wherein R1 represents a C1-C4 alkyl group optionally having a C1-C4 alkoxy group as a substituent, or a C3-C4 cycloalkyl group; R2 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having 1 to 5 C1-C4 alkoxy groups or fluorine atoms each as a substituent(s), or a C1-C6 alkoxy group; R3 represents a hydrogen atom, or a C1-C4 alkyl group optionally having 1 to 5 fluorine atoms as a substituent(s); R4 represents a hydrogen atom or a C1-C4 alkyl group; and R5 represents a phenyl group optionally having 1 to 3 substituents selected from fluorine atoms and chlorine atoms.
A compound represented by formula (I):
The compound:
The compound:
The compound:
Dependencies are inferred from the claim text.